Nathan Rice Stock Analyst Profile - Piper Sandler Research Coverage - Stocknear

Nathan Rice

Stock Analyst at Piper Sandler

(4.35)
# 1642
Out of 5,506 analysts
63
Total ratings
Success rate
Average return

16 Stocks

Name Action PT Current % Upside Ratings Updated
MBIN Merchants Bancorp
Maintains: Overweight
42 41
32.17 27.45% 8 Jul 30, 2025
FMBH First Mid Bancshares
Maintains: Overweight
47 49
37.48 30.74% 4 Jul 28, 2025
BFC Bank First
Maintains: Neutral
115 137
128.34 6.75% 8 Jul 21, 2025
BY Byline Bancorp
Reiterates: Overweight
34 34
27.62 23.1% 8 Oct 29, 2024
CVS CVS Health
Maintains: Buy
85 74
77.49 -4.5% 2 May 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Assumes: Neutral
84
133.52 -37.09% 1 Jan 10, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Sell
197
132.17 49.05% 8 Dec 11, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
11 9
20.64 -56.4% 1 Apr 25, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Sell
40
n/a n/a 1 Dec 13, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
530 435
631.19 -31.08% 4 Jul 21, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
233
310.96 -25.07% 3 Dec 14, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
83
38.73 114.3% 4 Dec 14, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Overweight
15
17.26 -13.09% 1 Dec 19, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Upgrades: Buy
49 54
n/a n/a 4 Feb 8, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Overweight
30 31
n/a n/a 2 Jul 27, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 4 Jul 24, 2017